Insider Purchases: Inside the Buy
Tag: Short Interest
Enphase Energy: The Comeback Nobody Believed (But the CEO Keeps Buying)
Enphase Energy fell hard after its solar boom—but the CEO keeps buying, institutions still dominate the float, and shorts are piled in. Here’s why ENPH might be starting to sync back in—and what investors should really watch. 🌞🔋
Update on High-Risk, High-Reward Intellia Therapeutics: Another Insider Buys — Should You?
NTLA is the kind of stock that tests both your thesis and your pulse. Short interest sits around 36%, the FDA put a key trial on hold, and yet directors just bought ~$2.4M in shares. Here’s the fun-but-serious update on the squeeze setup, the catalysts, and the risks.
Insiders Buy Mercer’s Stock, But Who Will Have Mercy on MERC?
Insiders are buying Mercer International (MERC), valuation screens look broken, and shorts are circling. Cheap stock — or classic value trap? 🌲📉
Insider Buys: Should You Root for Sprout Social — Or Be-Leaf It’s a Loon’s Call?
Sprout Social fell from SaaS stardom to near all-time lows — but insiders are buying, institutions own the float, and valuation looks compelling. Is SPT a fallen tree… or a healthy sapling ready to regrow?
Fiserv: Can Its Clover Come with Four Leaves Or Is It Just Three for Faith, Hope, and Love?
Insiders are buying, institutions are loading up, shorts are barely awake, and Fiserv now trades at deep-value multiples. With Clover, cash flow, and a credible turnaround plan, is this three-leaf fintech about to sprout a fourth? 🍀